Early estimates of seasonal influenza vaccine effectiveness in Europe: Results from the I-MOVE multicentre case-control study, 2012/13

Eurosurveillance

Volumn 18, Issue 7, 2013, Pages

  Valenciano, M ^a   Kissling, E ^a  

^a EPICONCEPT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DRUG EFFICACY; DYSPNEA; EUROPE; FEMALE; FEVER; HEADACHE; HEALTH PRACTITIONER; HOSPITALIZATION; HUMAN; INFANT; INFLUENZA; INFLUENZA A; INFLUENZA B; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYALGIA; NASOPHARYNGEAL ASPIRATION; NEWBORN; PRESCHOOL CHILD; SORE THROAT;

EID: 84874138699     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Kissling E, Valenciano M, Cohen JM, Oroszi B, Barret AS, Rizzo C, et al. I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe. PLoS One. 2011;6(11):e27622.
2. Kissling E, Valenciano M; I-MOVE case-control studies team. Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study. Euro Surveill. 2011;16(11):pii=19818. Available from: http:// www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19818
3. Kissling E, Valenciano M; I-MOVE Case-Control Studies Team. Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12. Euro Surveill. 2012;17(15):pii=20146. Available from: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=20146
4. Valenciano M, Kissling E, Cohen JM, Oroszi B, Barret AS, Rizzo C, et al. Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study. PLoS Med. 2011;8(1):e1000388.
5. Valenciano M, Ciancio B, I-MOVE study team. I-MOVE: a European network to measure the effectiveness of influenza vaccines. Euro Surveill. 2012;17(39):pii=20281. Available from: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=20281
6. Castilla J, Morán J, Martínez-Artola V, Fernández-Alonso M, Guevara M, Cenoz MG, et al. Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: cohort and case control study. Vaccine. 2011;29(35):5919-24. http://dx.doi.org/10.1016/j.vaccine.2011.06.063 PMid:21723358
7. Pebody R, Hardelid P, Fleming D, McMenamin J, Andrews N, Robertson C, et al. Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11. Euro Surveill. 2011;16(6):pii=19791. Available from: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=19791
8. European Centre for Disease Prevention and Control (ECDC). European Influenza Surveillance Network (EISN). Stockholm: ECDC. [Accessed 5 Feb 2013]. Available from: http://www.ecdc. europa.eu/en/activities/surveillance/eisn/pages/index.aspx
9. Kissling E, Valenciano M, Larrauri A, Oroszi B, Cohen J. M, Nunes B, et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. Euro Surveill. 2013;18(5):pii=20390. Available from: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=20390
10. European Commission. Commission Decision of 30 April 2009 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council (2009/363/EC). Official Journal of the European Union. Luxembourg: Publications Office of the European Union. 1.5.2009 L 110. Available from: http://eur-lex. europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2009:110:0058: 0059:EN:PDF
11. European Centre for Disease Prevention and Control (ECDC). Weekly influenza surveillance overview, 25 January 2013. Main surveillance developments in week 3/2013 (14-20 January 2013). Stockholm: ECDC; 2013. Available from: http://www. ecdc.europa.eu/en/publications/Publications/130125_SUR_ Weekly_Influenza_Surveillance_Overview.pdf
12. Skowronski DM, Januja NZ, De Serres G, Dickinson JA, Winter A-L, Mahmud SM, et al. Interim estimates of influenza vaccine effectiveness in 2012/13 from Canada's sentinel surveillance network, January 2013. Euro Surveill. 2013;18(5):pii=20394. Available from: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=20394
13. Centers for Diseases Control and Prevention (CDC). Early estimates of seasonal influenza vaccine effectiveness-United States, January 2013. MMWR Morb Mortal Wkly Rep. 2013;62(02):32-5. Available from: http://www.cdc.gov/mmwr/ preview/mmwrhtml/mm6202a4.htm?s_cid=mm6202a4_w
14. Buda S, Schweiger B, Buchholz U, Köpke K, Luchtenberg M, Prahm K, et al. Kalenderwoche 4 (19.01. bis 25.01.2013). Influenza-Wochenbericht. [Week 4 (19.01 to 25.01.20130. Influenza weekly report]. Berlin: Robert Koch Institute; 2013. Available from: http://influenza.rki.de/ Wochenberichte/2012_2013/2013-04.pdf
15. European Centre for Disease Prevention and Control (ECDC). Influenza virus characterisation. Summary Europe, December 2012. Stockholm: ECDC; 2013. Available from: http://ecdc. europa.eu/en/publications/Publications/influenza-viruscharacterisation-CNRL-dec-2012.pdf
16. McMenamin J, Andrews N, Robertson C, Fleming DM, Durnall H, Von Wissmann B, et al. Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: mid-season analysis 2012/13. Euro Surveill. 2013;18(5):pii=20393. Available from: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=20393